Management Team

Dr. Scott Wolf is a prolific medical device entrepreneur with a long history of developing aesthetic medicine therapies. Scott is the founder of Zeltiq Aesthetics, the maker of CoolSculpting, the leading non-invasive method of fat reduction for bodysculpting.  Zeltiq was acquired by Allergan for $2.5B. Scott was also a board observer with Kythera, which developed Kybella, an injectable compound for fat removal. Kythera was also acquired by Allergan for $2B. Scott is also the founder of Aerin Medical which developed a non-surgical therapy for patients with nasal obstruction. Scott was a partner at Prospect Venture Partners and a vice-president at Frazier Healthcare Ventures, both leading life science venture capital firms. Scott received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.

Richard J. Prati, a seasoned business executive, investor, entrepreneur, philanthropist, and hands-on turnaround specialist, has served as Chief Executive Officer of Life Care Medical Devices since November 2013 (, and CEO of Prati Management, a Family Office since 2012.  Richard has 25 years of proven financial leadership and operational execution in investment banking, institutional equity sales, and professional investment management. As a Principal at several notable Wall Street investment firms, Mr. Prati has a strong history of exceptional value creation and a successful track record of transformational, business turnaround expertise including sourcing and executing transactions, accessing the public and private markets and catalyzing sizable revenue growth production. He has guided a wide range of emerging and established public and private entities in industries ranging from healthcare, biotech, medical devices, conglomerates, retail, industrials, information technology and semiconductors companies.

Mr. Prati Co-Founded, a young medical technology start-up, Singular Medical Technologies, Inc. (, and serves as Chairman. Singular addresses in a unique and innovative way the global problem of PACS incompatibility and hospital consolidation. Mr. Prati also recently served as Vice Chairman of PVG Asset Management (, a fund family with nearly $1 Billion in assets for three years, and is a board member and early-stage investor of the privately-held Centennial Brands company. In 2002 Mr. Prati was one of two co-founders of American Technology Research (AmTech), an independent research broker/dealer and negotiated the $35 million sale of AmTech to Broadpoint in 2008. He then served as President and Vice Chairman of the equities division of Gleacher and Company (GLCH, which merged with Broadpoint AmTech shortly after the acquisition of AmTech). In 2010, Mr. Prati accepted the position Senior Managing Director of Equities at Sterne Agee, a large regional brokerage-firm that was recently acquired by Stifel Nicolaus. Prior to founding AmTech, Mr. Prati was a Senior Partner at SoundView Technology Group, ran the west coast and launched the Denver office as well as establishing firm records as the top revenue producer his final three years. Richard served as an Executive Director at SG Warburg (UBS) in institutional equity sales, after embarking on his successful Wall Street career as an investment banker at Dean Witter Reynolds (acquired by Morgan Stanley). He earned his MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester and his B.S in Economics from Vanderbilt University.

Mr. DeCiccio has his Master's in Finance and Systems Technology from the University of Southern California and his Bachelor's in Accounting and Finance from Loma Linda University. He is a Certified Public Accountant (active) having worked 4 years at Ernst & Young in its Orange County, California office.

Over 25 years of experience working in publicly traded companies including President at Cerebain Biotech Corp., CFO/COO at Intech Electromechanical, and CFO/COO at GTC Telecom. Mr. DeCiccio also served as Controller at Parker Hannifin Corp., Waste Management Inc., Newport Corp., and Ritz Interactive. In these roles, he has managed the finance, accounting, SEC reporting, treasury, human resources, investor relations, and legal departments.

Mr. DeCiccio has also been a member of the Board of Directors and Audit Committee for Interplay Entertainment, Inc., and GT Data Corp.

Dr. Camran Nezhat has been called the father of modern-day operative laparoscopy for introducing the technique of video-assisted endoscopy.1-3 Along with his brothers, Drs. Farr and Ceana Nezhat, and their teams, he performed some of the most advanced pathologies endoscopically for the first time. Thus, opened up the path and the landscape for endoscopic surgeons all over the world.1-41

Some of these procedures included: laparoscopic treatment of extensive endometriosis,4,5 bowel resection (including shaving technique, disk excision, segmental colon resection by natural orifice of vagina and rectum, also by mini laparotomy and total laparoscopy),6-17 bladder resection,18 ureter resection,19-21 diaphragm resection and reanastamosis22, radical hysterectomy with paraaortic and pelvic node dissection,15,16,23,24 management of ovarian remnant,25 laparoscopic-assisted myomectomy,26 sacral colpopexy,15,27 laparoscopic repair of vesico vaginal fistulas,28 operative laparoscopy during advanced pregnancy29, vaginal cuff dehiscence following laparoscopic hysterectomy,30 laparoscopic repair of major retroperitoneal vessels,31,32 laparoscopic repair of Cesarean section defect (Niche procedure),33 laparoscopic debulking for advanced ovarian cancer,34 laparoscopic treatment of liver endometriosis,35 and laparoscopic treatment of lung endometriosis.36,37 Drs. Nezhat also proposed a new classification for ovarian endometriomas, based on the pathological findings.38 These were all among some of the procedures performed endoscopically, for the first time, by Camran Nezhat, M.D. and his team.

Camran Nezhat, M.D. collaborated with robotic pioneers, Ajit Shah and Phil Green, in the 1990’s, for the development of the da Vinci Robot.

He is author of eight textbooks and several hundred articles, and has trained many physicians, who have become pillars of their communities, internationally.

He lives and practices medicine in the San Francisco Bay Area.

  1. Podratz, Karl, MD PHD. Degrees of Freedom: Advances in Gynecological and Obstetrical Surgery. Remembering Milestones and Achievements in Surgery: Inspiring Quality for a Hundred Years 1913--‐2012. Published by American College of Surgeons 2012. Tampa: Faircount Media Group; 2013.
  2. Carter JE. Biography of Camran Nezhat, MD, FACOG, FACS. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2006;10 (2):275-­‐280.
  3. Kelley WE. The Evolution of Laparoscopy and the Revolution in Surgery in the Decade of the 1990s. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2008;12(4):351-­‐357.
  4. Nezhat C. Laser laparoscopy for the treatment of endometriosis. Paper presented at: Conjoint Meeting of the American Society for Reproductive Medicine and the Canadian Fertility and Andrology Society; 1985; Toronto, Canada
  5. Nezhat, C., Crowgey, S. R. & Garrison, C. P. Surgical treatment of endometriosis via laser laparoscopy. Fertility & Sterility. P 45, 778 -­‐ 783. (1986)
  6. Nezhat C, Nezhat F. Evaluation of safety of videolaseroscopic treatment of bowel endometriosis, Scientific Paper, 44th Annual Meeting of the American Fertility Society, Atlanta Hilton and Towers, Atlanta, Georgia, October 8 ­‐- 13, 1988
  7. Nezhat CR, Nezhat FR. Safe laser excision and vaporization of endometriosis. Fertil Steril, 1989; P 52(1): 149 – 151
  8. Nezhat C, Pennington E, Nezhat F, Silfen SL. Laparoscopically assisted anterior rectal wall resection and reanastomosis for deeply infiltrating endometriosis. Surg Laparosc Endosc, June 1991;1(2): 106 ­‐- 108.
  9. Nezhat F, Nezhat C, Pennington E. Laparoscopic proctectomy for infiltrating endometriosis of the rectum. Fertil Steril, May 1992;57(5): 1129 -­‐ 1132.
  10. Nezhat F, Nezaht C, Pennington E, Ambroze W Jr. Laparoscopic segmental resection for infiltrating endometriosis of the recto sigmoid colon: a preliminary report, Surg Laparosc Endoc. 1992;2:212-216
  11. Nezhat C, Nezhat F, Pennington E. Laparoscopic treatment of lower colorectal and infiltrating rectovaginal septum endometriosis by the technique of videolaserooscopy. Br J Obstet Gynae- col. 1992;99:664-667
  12. Nezhat C, Nezhat F, Nezhat CH. Surgery for Endometriosis of the Bowel, Bladder, Ureter, and Diaphragm. Annals of the New York Academy of Sciences, 1997; 828: 332-340
  13. Nezhat C, Nezhat F, Pennington E, et al. Laparoscopic disk excision and primary repair of the anterior rectal wall for the treatment of full thickness bowel endometriosis, Surg Endosc. 1994;8:682-685
  14. Nezhat C, Nezhat F, Ambroze W. & Pennington E, Laparoscopic repair of small bowel and colon: A report of 26 causes. Surg Endosc. P 7(2): 88-89, (1993)
  15. Nezhat, C, Nezhat F, Nezhat C, Operative laparoscopy (minimally invasive surgery). State of the art, J Gynecol Surg. 1992; 8:111-141.
  16. Nezhat C, Nezhat F. Stilfen SL, Videolaseroscopy: the CO2 laser for advanced operative laparoscopy. Obstet Gynecol Clin North Am. 1991; 18:585-604
  17. Nezhat F. Triumphs and controversies in laparoscopy: the past, the present, and the future. JSLS, 2003; 7:1 – 5.
  18. Nezhat C, Nezhat F. Laparoscopic segmental bladder resection for endometriosis: a report of two cases. Obstet Gynecol. 1993;81:882-884
  19. Nezhat C, Nezhat F, Green B. Laparoscopic treatment of obstructed ureter due to endometriosis by resection and ureteroureterostomy. A case report. J Urol. 1992; 148:865-868.
  20. Nezhat CH, Malik S, Nezhat F, Nezhat C. Laparoscopic ureteroneocystostomy and vesicopsoas hitch for infiltrative endometeriosis, 2004; 8:3-7.
  21. Nezhat CH, Nezhat F, freiha F, Nezhat C. Laparoscpic vesicopsoas hitch for infiltrative ureteral endometriosis. Fertil Steril. 1999;71:376-379.
  22. Nezhat F, Nezhat C, Levy JS. Laparoscopic treatment of symptomatic diaphragmatic endometriosis: A case report. Fertil Steril. 1992;58:614-616.
  23. Nezhat C, Burrell M, Nezhat F, Benigno B, Welander CE. Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol. 1992; 166:864-865.
  24. Nezhat CR, Nezhat FR, Ramirez CE, et al. Laparoscopic radical hysterectomy and laparoscopic assisted vaginal radical hysterectomy with pelvic and paraaortic node dissection, J Gynecol Surg. 1993; 9:105-120.
  25. Nezhat F, Nezhat C. Operative laparoscopy for the treatment of ovarian remnant syndrome. Fertil Steril, May 1992;57(5): 1003 – 1007.
  26. Nezhat C, Nezhat F, Bess O, Nezhat CH, Mashiach R. Laparoscopically assisted myomectomy: a report of a new technique in 57 cases, Intl J Fertil Menopausal Stud. P 39(1): 39 – 44. (1994)
  27. Nezhat F, Nezhat C, Nezhat CH. Laparoscopic sacral colpopexy for vaginal wall prolapse. Obstet Gynecol. 1994;84:885 – 888.
  28. Nezhat CH, Nezhat F, Nezhat C, Rottenberg H. Laparoscopic repair of a vesicovaginal fistula: a case report. Obstet Gynecol. 1994;883:889 -901.
  29. Nezhat F, Nezhat C, Silfen S, Fehnel S. Laparoscopic treatment of ovarian cyst during pregnancy. J Laparoendosc Surg. 1991;1:161-164.
  30. Nezhat CH, Nezhat F, Seidman DS, Nezhat C. Vaginal vault evisceration after total laparoscopic hysterectomy. Obstet Gynecol 1996;87 : 868 – 870.
  31. Nezhat C, Childers J, Nezhat F, et al. Major retroperitoneal vascular injury during laparoscopic surgery. Hum Reprod. 1997 ; 12:480 – 483.
  32. Jacobson M, Oesterling S, Milki A, Nezhat CR. Laparoscopic control of a leaking inferior mesenteric vessel secondary to trocar injury. JSLS. 2002;6:389-391.
  33. Jacobson M, Osias J, Velasco A, Charles R, Nezhat C. Laparoscopic repair of a uteroperitoneal fistula. 2003;7:367-369.
  34. Amara DP, Nezhat C, Teng NN, Nezhat C, Rosati M. Operative laparoscopy in the management of ovarian cancer. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. P 6(1):38 – 45. (1996)
  35. Nezhat C, Kaerooni T, Berker B, LaShay N, Susan Fernan- dez S, Marziali M. Laparoscopic management of hepatic endometriosis: report of Two Cases and review of literature. J Min Invas Gynecol. 2005;12:196-200.
  36. Nezhat C, King LP, Paka C, Odegaard J, Beygui R. Bilateral thoratic endometriosis affecting the lung and diaphragm. JSLS : Journal of the Society of Laparoendoscopic Surgeons. P 6:140 – 142. (2012)
  37. Nezhat C, Main J, Paka C, Nezhat A, Beygui R. Multidisciplinary Treatment for Thoracic and Abdominopelvic Endometriosis. Journal of the Society of Laparoendoscopic Surgeons. Vol 18, Issue 3, July-Sept. (2014)
  38. Nezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL. Clinical and histologic classification of endometriomas: implications for a mechanism of pathogenesis. J Repro Med. 1992;37:771-776
  39. Nezhat C, My Journey with AAGL. Journal of Minimally Invasive Gynecology. 2010; 17(3): 271-277.
  40. Nezhat C. Operative endoscopy will replace almost all open procedures. JSLS. 2004;8:101-102.
  41. Nezhat C. 2005 Presidential address. JSLS 2005; 9:370-375.

Some other early reports, by Drs. Camran, Farr, and Ceana Nezhat, in peer reviewed journals:

  1. Nezhat C, Winer WK, Nezhat F. Laparoscopic removal of dermoid cysts. Obstet Gynecol, February 1989;73(2): 278 -- 281.
  2. Nezhat F, Winer WK, Nezhat, C. Fimbrioscopy and salpingoscopy in patients with minimal to moderate pelvic endometriosis. Obstetrics and Gynecology. P 75(1): 15 – 17. (1990)
  3. Nezhat F, Nezhat C, Gordon S, Wilkins E. Laparoscopic versus abdominal hysterectomy. J Reprod Med, March 1992;37(3):247 – 250.
  4. Nezhat C, Nezhat F, Burrell M. Laparoscopically assisted hysterectomy for the management of borderline ovarian tumor: A case report. J Laparoendosc Surg, Aug 1992; 2(4): 167 -169
  5. Nezhat C, Lavie O, Lemyre M, Gemer O, Bhagan L, Nezhat CH. Laparoscopic hysterectomy with and without a robot: Stanford experience. JSLS. P 13(2): 125 – 128. (2009)
  6. Nazhat C, Lavie O, Hsu S, Watson J, Barnett O, Lemyre M. Robotic-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy – a retrospective matched control study. Fertility and Sterility Vol. 91 (2), p 556 – 565. (2009)
  7. Nezhat C, Lavie O, Lemyre M, Unal E, Nezhat CH, Nezhat FR, Robotic-Assisted Laparoscopic Surgery in Gynecology: Scientific Dream or Reality? Fertility and Sterility, Volume 91, Issue 6, P 2620 – 2622, (2008).
  8. Nezhat C, Saberi NS, Shahmohamady B, Nezhat F. Robotic-assisted laparoscopy in gynecological surgery JSLS. Vol 10 (3), p 317 – 320. (206)
  9. Nezhat C, Hajhosseini B, King LP. Robotic-assisted laparoscopic treatment of bowel, bladder, and ureteral endometriosis. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. P 15: 387 – 392. (2011)

Mr. Mannheim practices in the area of corporate and securities law, including public offerings, venture capital financings, private placements, strategic partnerships, licensing and contracts. His experience ranges from representing start-up companies in their initial organization and seed financing to representing mature companies in public offerings, acquisitions and divestitures. Mr. Mannheim has particular experience in working with private equity backed healthcare services and life sciences companies.

Mr. Mannheim has been an attorney with Wyrick Robbins since 2000 and joined the firm from his previous practice with Alston & Bird LLP. He received both his B.B.A., summa cum laude, and his J.D., cum laude, from the University of Georgia in Athens, Georgia.

Robin Stephens joined Life Care Medical Devices in April 2015 as Chief Operating Officer. He has more than twenty years of pharmaceutical, regulatory and medical device experience and has held numerous C-level and Board Member positions. Mr. Stephens has been CEO & Principal Consultant at Psephos Biomedica since he founded the company in 2001. Psephos Biomedica is a medical technology consultancy in client-partnerships with entrepreneurial corporations, university spin-outs and venture-backed companies. From 2012 to 2014 Mr. Stephens was Director QA/RA/CA for Apica Cardiovascular in Galway, Ireland. He was part of the Apica M&A team that led to the acquisition of the company in July 2014 by the Thoratec Corporation. Since 2009 Mr. Stephens has also served as a Board Member and Director for Oxymon Limited, a UK based company developing a long-term oxygen therapy monitoring device. He has held senior positions with Conor MedSystems, Medtronic, Arterial Vascular Engineering and earlier held several roles within CR Bard.  Mr. Stephens holds a Masters Degree in Applied Theology from University of Wales, Bangor and a Bachelor of Science degree in Applied Chemistry from Northumbria University.

Jacques du Preez started working with Life Care Medical Devices in April 2015 initially as their International Finance Lead and subsequently as Interim CFO. Most recently he moved to Operations Director MIS effective from 1 February 2016.

Jacques has more than twenty-five years operations and finance experience in developed and emerging markets and more than 10 years medical services, medical devices and medical technology experience.

A Chartered Accountant he trained with Deloitte and completed his MBA at London Business School.

He has held a number of CFO, COO and board member positions and has been involved with and responsible for building several venture capital and private equity investments in the US, Europe and China.